Who are Placebo to Acetaminophen/Paracetamol's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Per Os Acetaminophen, Metamizole and Acetaminophen iv.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/placebo-to-acetaminophen-paracetamol.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Placebo to Acetaminophen/Paracetamol — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Placebo to Acetaminophen/Paracetamol (Placebo to Acetaminophen/Paracetamol) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Non-opioid analgesic and antipyretic. Area: Pain Management.

phase 3 Non-opioid analgesic and antipyretic Cyclooxygenase (COX) Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Placebo to Acetaminophen/Paracetamol (Placebo to Acetaminophen/Paracetamol) — Merck Sharp & Dohme LLC. Acetaminophen reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Placebo to Acetaminophen/Paracetamol TARGET	Placebo to Acetaminophen/Paracetamol	Merck Sharp & Dohme LLC	phase 3	Non-opioid analgesic and antipyretic	Cyclooxygenase (COX)
Per Os Acetaminophen	Per Os Acetaminophen	Hospital for Special Surgery, New York	marketed	Non-opioid analgesic and antipyretic	Cyclooxygenase (COX), primarily in central nervous system
Metamizole and Acetaminophen iv	Metamizole and Acetaminophen iv	Hospital General Universitario Elche	phase 3	Non-opioid analgesic and antipyretic combination	Cyclooxygenase (COX) enzymes; central pain and temperature regulation pathways

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Non-opioid analgesic and antipyretic class)

Hospital for Special Surgery, New York · 1 drug in this class
Merck Sharp & Dohme LLC · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Placebo to Acetaminophen/Paracetamol — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-acetaminophen-paracetamol. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab